MedTrace Logo

Effects of Lumber Sustained Natural Apophyseal Glides on Lower Cross Syndrome

NCT06707805 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-02-21

No results posted yet for this study

Summary

A sustained natural apophyseal glide (SNAG) is a mobilization technique commonly used in the treatment of painful movement restrictions of the spine.Studing the effect of Lumber SNAGs in lower cross syndrome hold significance due to its potential to correct pain, hypomobility and biomechanical changes i.e hyperlordotic curve and anterior pelvic tilting caused by lower cross syndrome. The specific muscle imbalance seen in PCS gives rise to specific joint dysfunction, particularly in the L4-L5 and L5-S1 segment of the vertebral column. Over time, this causes stress at the L5-S1 segment of the vertebral column leading to pain and irritation in the lower back Lumber SNAGs encourage improvement of these repositioning error, posture, alleviate discomfort and enhance overall functioning. This research aims to offer patients a noninvasive and personalized approach to managing LCS, ultimately contributing to their overall well-being and movement quality

Conditions

  • Lower Cross Syndrome

Interventions

OTHER

Traditional Physical therapy

Conventional treatment protocol including moist Heating pad for low back pain for 15 minutes. TENS for pain for 10 minutes. Stretchings of tight muscles would be 1 set of 5-7 reps with 5 sec. hold 3 times a week. Strengthing of weak muscles would be 2-3 times a weak with 10-15 reps.Stretching protocol will be followed for Iliopsoas and erector spinae muscles. Strengthening protocol will be followed for weak abdominals and Gluteus maximus muscles

OTHER

lumber SNAGS

: Lumber mobilizations with conventional treatment protocol. * Lumber Mulligan(SNAGs) technique * Technique applied at L4-L5, L5-S1 level. * Techniques applied for flexion ,extension, side bending and rotation 6 to 8 cycles per session

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Asmar Fatima, MS OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06707805 on ClinicalTrials.gov